BI
BioSyent Inc.
BIOYF · OTC
$11.35 -0.44% (-$0.05)
1M +6.97%
Market Cap $179.6M
P/E Ratio 18.19x
Div. Yield 1.34%
ROE 22.92%
Bulios Fair Price
$17.02
50.0% upside
Current Price
$11.35
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BIOYF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
71 /100
Cheap EV/EBITDA 11.73x
P/S 3.22x
P/B 3.92x
Growth
92 /100
Growing Rev. growth 15.49%
FCF growth 29.22%
Book val. growth 7.49%
Profitability
98 /100
Strong Net margin 17.72%
Op. margin 23.21%
FCF margin 21.18%
Quality
96 /100
Excellent ROE 22.92%
ROA 16.32%
Asset turnover 0.92x
Debt
100 /100
Low Current ratio 2.07x
Int. coverage 123.37x
Net debt/EBITDA -0.14x
Stability
100 /100
Stable Rev. volatility 6.33%
EPS volatility 0.75%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIOYF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
René C. Goehrum
Employees
711
Headquarters
Mississauga
Upcoming events
19 NOV
Earnings
Upcoming earnings report